Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Hoppe, Bernd ^a   Leumann, Ernst ^b   Von Unruh, Gerd ^c   Laube, Norbert ^c   Hesse, Albrecht ^c  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Hyperoxaluria; Nephrocalcinosis; Oxalate degrading bacteria; Oxalobacter formigenes; Review; Treatment; Urolithiasis; 13C 2 oxalate absorption test

Indexed keywords

CARBON 13; CITRIC ACID; OXALIC ACID; PHOSPHATE; PYRIDOXINE;

ABSORPTION; ANALYTICAL PARAMETERS; BACTERIAL METABOLISM; DIAGNOSTIC PROCEDURE; DIET; ENZYME REPLACEMENT; FECES ANALYSIS; HUMAN; HYPEROXALURIA; KIDNEY CALCIFICATION; MALABSORPTION; MEDICAL ASSESSMENT; METABOLISM; MICROBIAL DEGRADATION; NONHUMAN; REVIEW; RISK FACTOR; URINALYSIS; UROLITHIASIS;

BACTERIA (MICROORGANISMS); OXALOBACTER FORMIGENES;

EID: 3142744707     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Asplin, J.R.: Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 3, 927-49 (2002)
2. Hoppe, B., A. Jahnen, D. Bach, A. Hesse: Urinary calcium-oxalate saturation in healthy infants and children. J Urol 158, 557-559 (1997)
3. Leumann, E., B. Hoppe: The primary hyperoxalurias. J Am Soc Nephrol 12,1986-1993 (2001)
4. Holmes, R.P., H.O. Goodman, D.G. Assimos: Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59, 270-276 (2001)
5. Williams, H.E., T.R. Wandzilak: Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141 742-747 (1989)
6. Danpure, C.J., P.R. Jennings: Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201, 20-24 (1986)
7. Cramer, S.D., P.M. Ferree, K. Lin, D.S. Milliner, R.P. Holmes: The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Gen 8, 2063-2069 (1999)
8. Cregeen, D.P., G. Rumsby: Recent developments in our understanding of primary hyperoxaluria type 2. J Am Soc Neprol 10, 348-350 (1999)
9. Monico, C.G., M. Persson, G.C. Ford, G. Rumsby, D.S. Milliner: Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 62, 392-400 (2002)
10. Neuhaus, T.J., T. Beizer, N. Blau, B. Hoppe, H. Sidhu, E. Leumann: Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 82, 322-326 (2000)
11. Hoppe, B., M. J. Kemper, A. Bökenkamp, A.A. Portale, R.A. Cohn, C.B. Langman: Plasma calcium-oxalate supersaturation in children with primary hyperoxaluria and end stage renal disease. Kidney Int 56, 268-274 (1999)
12. Hoppe, B., A. Hesse, S. Brömme, E. Rietschel, D. Michalk: Urinary excretion substances in cystic fibrosis: risk of urolithiasis? Pediatr Nephrol 12, 275-279 (1998)
13. Turner, M.A., D. Goldwater, T.J. David: Oxalate and calcium excretion in cystic fibrosis. Arch Dis Child 83, 244-247 (2000)
14. Strandvik, B., L. Hjelte: Nephrolithiasis in cystic fibrosis. Acta Paediatr 82, 306-307 (1993)
15. Andersson, H., I. Bosaeus, S. Fasth, R. Hellberg, L. Hulten: Cholelithiasis and urolithiasis in Crohn's disease. Scand J Gastroenterol 22, 253-6 (1987)
16. Caudarella, R., E. Rizzoli, L. Pironi, N. Malavolta, G. Martelli, G. Poggioli, G. Gozzetti, M. Miglioli: Renal stone formation in patients with inflammatory bowel disease. Scanning Microscopy 7, 371-9 (1993)
17. Hylander, E., S. Jarnum, I. Frandsen: Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease. Scand J Gastroenterol 14, 475-9 (1979)
18. Kyle, J.: Urinary complications of Crohn's disease. World J Surg 4, 153-60 (1980)
19. Siener, R., A. Hesse: The effect of different diets on urine composition and the risk of calcium oxalate crystallization in healthy subjects. Eur Urol 42, 289-96 (2002)
20. Siener, R., D. Ebert, C. Nicolay, A. Hesse: Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int 63, 1037-1043 (2003)
21. Hönow, R., A. Hesse: Comparison of extraction methods for the determination of soluble and total oxalate in foods by HPLC-enzyme-reactor. Food Chem 78, 511-521 (2002)
22. Hesse, A., R. Siener: Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol 15, 165-71 (1997)
23. Massey, L.K., R.G. Palmer, H.A.T. Horner: Oxalate content of soybean seeds (Glycine max: Leguminosae), soyfoods, and other edible legumes. J Agric Food Chem 49, 4262-6 (2001)
24. 2]oxalate absorption test. J Urol 169, 687-90 (2003)
25. Ogawa, Y., T. Mijazato, T. Hatano: Oxalate and urinary stones. World J Surg 24, 1154-1159 (2000)
26. Hesse, A., R. Siener, H. Heynck, A. Jahnen: The influence of dietary factors on the risk of urinary stone formation. Scanning Microscopy 7, 1119-1128 (1993)
27. Auer, B.L., D. Auer, A.L. Rodgers: Relative hyperoxaluria, crystalluria and hematuria after megadose ingestion of vitamin C. Eur J Clin Invest 28, 695-700 (1998)
28. Massey, L.K.: Effects of ascorbate supplements on urinary oxalate and risk of kidney stones. J Am Diet Assoc 100, 516 (2000)
29. Calabria Baxmann, A., C. de O.G. Mendonca, I. Pfefferman Heilberg: Effect of vitamin C supplement on urinary oxalate and pH in calcium stone forming patients. Kidney Int 63, 1066-1071 (2003)
30. Nishijima, S., K. Sugaya, M. Morozumi, T. Hatano, Y. Ogawa: Hepatic alanine:glyoxylate aminotransferase activity and oxalate metabolism in vitamin B6 deficient rats. J Urol 169, 683-686 (2003)
31. Hoppe, B., A. Hesse, T. Neuhaus, S. Fanconi, I. Forster, N. Blau, E. Leumann: Urinary saturation and nephrocalcinosis in preterm infants: effect of parenteral nutrition. Arch Dis Child 69, 299-303 (1993)
32. Kumar, R., M. Mukherjee, M. Bhandari, A. Kumar, H. Sidhu, R.D. Mittal: Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41, 318-22 (2002)
33. Sidhu, H., M.E. Schmidt, J.G. Cornelius, S. Thamilselvan, S.R. Khan, A. Hesse, A.B. Peck: Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 14, S334-40 (1999)
34. Hirai, T., J.A.W. Heymann, D. Shi, R.Sarker, P.C. Maloney, S. Subramanian: Three-dimensional structure of a bacterial oxalate transporter. Nat Struct Biol 9, 597-599 (2002)
35. Hokama, S., Y. Honma, C. Toma, Y. Ogawa: Oxalate degrading Enterococcus faecalis. Microbiol Immunol 44, 235-240 (2000)
36. Campieri, C., M. Compieri, V. Bertuzzi, E. Swennen, D. Matteuzzi, S. Stefoni, F. Pirovano, C. Centi, S. Ulisse, G. Famularo, C. de Simone: Reduction of oxaluria after an oral course of lactic acid bacteria. Kidney Int 60, 1097-1105 (2001)
37. Sidhu, H., B. Hoppe, A. Hesse, K. Tenbrock, S. Brömme, E. Rietschel, A.B. Peck: Antibiotic induced loss of the gut associated bacterium Oxalobacter formigenes: a risk factor for hyperoxaluria in cystic fibrosis patients. Lancet 352, 1026-1030 (1998)
38. Hesse, A., H.G. Tiselius, A. Jahnen: Urinary stones: Diagnosis, treatment, and prevention of recurrence. 2nd Edition, Karger, Bale, Switzerland (2002)
39. Laube, N., M. Pullmann, S. Hergarten, A. Hesse: Influence of urinary stones on the composition of a 24 h urine sample. Clin Chem 49, 281-285 (2003)
40. Werness, P.G., C.M. Brown, L.H. Smith, B. Finlayson: Equil 2, a basic computer program for the calculation of urinary saturation. J Urol 134, 1242-1244 (1985)
41. Laube, N., V. Labedzke, S. Hergarten, A. Hesse A: Determination of urinary calcium-oxalate formation risk with BONN-Risk-index and EQUIL applied to a family. J Chem Inf Comput Sci 42, 633-639 (2002)
42. Laube, N., A. Schneider, A. Hesse: A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine. Urol Res 28, 274-280 (2003)
43. Laube, N., S. Hergarten, A. Hesse: Comparison of a laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate. Clin Chem Lab Med 40, 595-599 (2002)
44. Marangella, M., M. Petrarulo, C. Vitale, C. Bagnis, S. Berutti, A. Ramello, A. Amoroso: The primary hyperoxalurias. Contrib Nephrol 136, 11-32 (2001)
45. Hönow, R., A. Hesse: Interference-free sample preparation for the determination of plasma oxalate analyzed by HPLC-ER: preliminary results from calcium oxalate stone-formers and non stone-formers. Clin Chim Acta 318, 19-24 (2002)
46. Sidhu, H., R.P. Holmes, M.J. Allison, A.B. Peck AB: Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 37, 1503-1509 (1999)
47. 2]oxalate. J Am Soc Nephrol 10, S329-S333 (1999)
48. Sidhu, H., M.J. Allison, J.M. Chow, A. Clark, A.B. Peck: Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 166, 1487-1491 (2001)
49. Hatch, M., R.W. Freel: Renal and intestinal handling of oxalate following oxalate loading in rats. Am J Nephrol 23, 18-26 (2003)